ClinicalTrials.govpublic full text
Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies
subjects entering into this protocol will be followed for up to 15 years after initial cart-egfrviii infusion, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894669
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.